These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 20192727)

  • 41. The value of microscopic-observation drug susceptibility assay in the diagnosis of tuberculosis and detection of multidrug resistance.
    Sertel Şelale D; Uzun M
    APMIS; 2018 Jan; 126(1):38-44. PubMed ID: 29154391
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Direct Detection of Rifampin and Isoniazid Resistance in Sputum Samples from Tuberculosis Patients by High-Resolution Melt Curve Analysis.
    Anthwal D; Gupta RK; Bhalla M; Bhatnagar S; Tyagi JS; Haldar S
    J Clin Microbiol; 2017 Jun; 55(6):1755-1766. PubMed ID: 28330890
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Isoniazid and rifampin drug susceptibility testing: application of 2,3,5-triphenyl tetrazolium chloride assay and microscopic-observation drug-susceptibility assay directly on Ziehl-Neelsen smear positive sputum specimens.
    Shinu P; Singh V; Nair A
    Braz J Infect Dis; 2016; 20(1):33-40. PubMed ID: 26638012
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Anti-tuberculosis treatment outcomes in HIV-infected adults exposed to isoniazid preventive therapy in Botswana.
    Sibanda T; Tedla Z; Nyirenda S; Agizew T; Marape M; Miranda AG; Reuter H; Johnson JL; Samandari T
    Int J Tuberc Lung Dis; 2013 Feb; 17(2):178-85. PubMed ID: 23317952
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Reliability of the MODS assay decentralisation process in three health regions in Peru.
    Mendoza A; Castillo E; Gamarra N; Huamán T; Perea M; Monroi Y; Salazar R; Coronel J; Acurio M; Obregón G; Roper M; Bonilla C; Asencios L; Moore DA
    Int J Tuberc Lung Dis; 2011 Feb; 15(2):217-22, i. PubMed ID: 21219684
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical evaluation of the microscopic-observation drug-susceptibility assay for detection of tuberculosis.
    Arias M; Mello FC; Pavón A; Marsico AG; Alvarado-Gálvez C; Rosales S; Pessôa CL; Pérez M; Andrade MK; Kritski AL; Fonseca LS; Chaisson RE; Kimerling ME; Dorman SE
    Clin Infect Dis; 2007 Mar; 44(5):674-80. PubMed ID: 17278058
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Molecular detection of rifampin and isoniazid resistance to guide chronic TB patient management in Burkina Faso.
    Miotto P; Saleri N; Dembelé M; Ouedraogo M; Badoum G; Pinsi G; Migliori GB; Matteelli A; Cirillo DM
    BMC Infect Dis; 2009 Aug; 9():142. PubMed ID: 19715569
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cost-effectiveness analysis of microscopic observation drug susceptibility test versus Xpert MTB/Rif test for diagnosis of pulmonary tuberculosis in HIV patients in Uganda.
    Walusimbi S; Kwesiga B; Rodrigues R; Haile M; de Costa A; Bogg L; Katamba A
    BMC Health Serv Res; 2016 Oct; 16(1):563. PubMed ID: 27724908
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of the tuberculosis culture color plate test for rapid detection of drug susceptible and drug-resistant Mycobacterium tuberculosis in a resource-limited setting, Addis Ababa, Ethiopia.
    Mekonnen B; Mihret A; Getahun M; Hailu T; Sidiki S; V Kelley H; Scordo JM; Hunt WG; Pan X; Balada-Llasat JM; Gebreyes W; Evans CA; Aseffa A; Torrelles JB; Wang SH; Abebe T
    PLoS One; 2019; 14(5):e0215679. PubMed ID: 31136575
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of isoniazid resistance on TB treatment outcomes under programmatic conditions in a high-TB and -HIV setting: a prospective multicentre study.
    Nagu TJ; Aboud S; Matee MI; Maeurer MJ; Fawzi WW; Mugusi F
    J Antimicrob Chemother; 2017 Mar; 72(3):876-881. PubMed ID: 27999054
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Bacterial risk factors for treatment failure and relapse among patients with isoniazid resistant tuberculosis.
    Thai PVK; Ha DTM; Hanh NT; Day J; Dunstan S; Nhu NTQ; Kiet VS; Lan NH; Dung NH; Lan NTN; Thuong NT; Lan NN; Liễu PTT; Hồng NT; Điệp ĐC; Thanh NTK; Hội NV; Nghĩa NV; Đại TN; Minh HQ; Thơm NV; Farrar J; Caws M
    BMC Infect Dis; 2018 Mar; 18(1):112. PubMed ID: 29510687
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Basis for treatment of tuberculosis among HIV-infected patients in Tanzania: the role of chest x-ray and sputum culture.
    Bakari M; Arbeit RD; Mtei L; Lyimo J; Waddell R; Matee M; Cole BF; Tvaroha S; Horsburgh CR; Soini H; Pallangyo K; von Reyn CF
    BMC Infect Dis; 2008 Mar; 8():32. PubMed ID: 18325120
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A prospective cohort study of outcomes for isoniazid prevention therapy: a nested study from a national QI collaborative in Uganda.
    Sensalire S; Karungi Karamagi Nkolo E; Nabwire J; Lawino A; Kiragga D; Muhire M; Kadama H; Katureebe C; Namuwenge P; Musinguzi J; Calnan J; Seyoum D
    AIDS Res Ther; 2020 May; 17(1):28. PubMed ID: 32460788
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation of genotype MTBDRplus VER 2.0 line probe assay for the detection of MDR-TB in smear positive and negative sputum samples.
    Meaza A; Kebede A; Yaregal Z; Dagne Z; Moga S; Yenew B; Diriba G; Molalign H; Tadesse M; Adisse D; Getahun M; Desta K
    BMC Infect Dis; 2017 Apr; 17(1):280. PubMed ID: 28415989
    [TBL] [Abstract][Full Text] [Related]  

  • 55. TB or not TB? Definitive determination of species within the Mycobacterium tuberculosis complex in unprocessed sputum from adults with presumed multidrug-resistant tuberculosis.
    Mbelele PM; Sauli E; Mpolya EA; Mohamed SY; Addo KK; Mfinanga SG; Heysell SK; Mpagama S
    Trop Med Int Health; 2021 Sep; 26(9):1057-1067. PubMed ID: 34107112
    [TBL] [Abstract][Full Text] [Related]  

  • 56. M. tuberculosis genotypic diversity and drug susceptibility pattern in HIV-infected and non-HIV-infected patients in northern Tanzania.
    Kibiki GS; Mulder B; Dolmans WM; de Beer JL; Boeree M; Sam N; van Soolingen D; Sola C; van der Zanden AG
    BMC Microbiol; 2007 May; 7():51. PubMed ID: 17540031
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Detection of a substantial rate of multidrug-resistant tuberculosis in an HIV-infected population in South Africa by active monitoring of sputum samples.
    Hassim S; Shaw PA; Sangweni P; Malan L; Ntshani E; Mathibedi MJ; Stubbs N; Metcalf JA; Eckes R; Masur H; Komati S
    Clin Infect Dis; 2010 Apr; 50(7):1053-9. PubMed ID: 20196651
    [TBL] [Abstract][Full Text] [Related]  

  • 58. High Mycobacterium tuberculosis Bacillary Loads Detected by Tuberculosis Molecular Bacterial Load Assay in Patient Stool: a Potential Alternative for Nonsputum Diagnosis and Treatment Response Monitoring of Tuberculosis.
    Musisi E; Sessolo A; Kaswabuli S; Zawedde J; Byanyima P; Kasinga S; Sanyu I; Uwimaana E; Walimbwa S; Olore J; Ssengooba W; Sekaggya C; Joloba ML; Worodria W; Huang L; Gillespie SH; Sloan DJ; Sabiiti W
    Microbiol Spectr; 2022 Feb; 10(1):e0210021. PubMed ID: 35019686
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Intensified tuberculosis case-finding in HIV-positive adults managed at Ethiopian health centers: diagnostic yield of Xpert MTB/RIF compared with smear microscopy and liquid culture.
    Balcha TT; Sturegård E; Winqvist N; Skogmar S; Reepalu A; Jemal ZH; Tibesso G; Schön T; Björkman P
    PLoS One; 2014; 9(1):e85478. PubMed ID: 24465572
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The effect of isoniazid preventive therapy on incidence of tuberculosis among HIV-infected clients under pre-ART care, Jimma, Ethiopia: a retrospective cohort study.
    Assebe LF; Reda HL; Wubeneh AD; Lerebo WT; Lambert SM
    BMC Public Health; 2015 Apr; 15():346. PubMed ID: 25886730
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.